Equity

6 Months Ended

Jun. 28, 2020

Equity [Abstract]

Equity

Equity

A. Preferred Stock

Prior to May 4, 2020, Pfizer’s Series A convertible perpetual preferred stock (the Series A Preferred Stock) was held by an employee stock ownership plan trust (the Trust). All outstanding shares of Series A Preferred Stock were converted, at the direction of the independent fiduciary under the Trust and in accordance with the certificate of designations for the Series A Preferred Stock, into shares of Pfizer common stock on May 4, 2020. The Trust received an aggregate of 1,070,369 shares of Pfizer common stock upon conversion, with zero shares of Series A Preferred Stock remaining outstanding as a result of the conversion.

B. Dividends

The following table summarizes quarterly cash dividends:
2020			2019
Date Declared	Payment Date	Dividend Per Share	Date Declared	Payment Date	Dividend Per Share
December 13, 2019	March 6, 2020	0.38	December 14, 2018	March 1, 2019	0.36
April 23, 2020	June 5, 2020	0.38	April 25, 2019	June 7, 2019	0.36
June 25, 2020	September 1, 2020	0.38	June 27, 2019	September 3, 2019	0.36
			September 24, 2019	December 2, 2019	0.36